Cargando…
G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey
BACKGROUND: Current guidelines (GL) recommend neutropenia prophylaxis with G-CSF after chemotherapy (CTX) for patients with high (≥ 20%), or, if additional risk factors are present, intermediate (≥ 10–20%) risk of febrile neutropenia. The first sample survey in 2012 (NP1) showed lack of GL adherence...
Autores principales: | Link, Hartmut, Kerkmann, Markus, Holtmann, Laura, Ortner, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394812/ https://www.ncbi.nlm.nih.gov/pubmed/30374765 http://dx.doi.org/10.1007/s00520-018-4481-x |
Ejemplares similares
-
Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections
por: Link, Hartmut, et al.
Publicado: (2022) -
Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
por: Link, Hartmut, et al.
Publicado: (2019) -
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
por: Link, Hartmut
Publicado: (2022) -
G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung: Supportivtherapieleitlinien, Teil 1
por: Link, Hartmut
Publicado: (2022) -
G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung: Supportivtherapieleitlinien, Teil 1
por: Link, Hartmut
Publicado: (2022)